Malvern, PA, United States
Malvern, PA, United States

Neuronetics is a privately held company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. The NeuroStar transcranial magnetic stimulation therapy system was developed for treating major depression in patients who have not benefitted from prior antidepressant medications.Neuronetics was founded within The Innovation Factory, an Atlanta, GA-based medical technology incubator. The Company has raised venture capital based on its intellectual property portfolio and management team. Neuronetics’ investors include life-sciences firms such as Quaker BioVentures, Three Arch Partners, Investor Growth Capital, Onset Ventures, Interwest Partners, KBL Healthcare Ventures, Accuitive Medical Ventures and New Leaf Venture Partners.On September 1, 2010, the World Economic Forum announced the company as a Technology Pioneer for 2011. Wikipedia.


Time filter

Source Type

Patent
Neuronetics | Date: 2017-04-12

Disclosed is a system for reducing discomfort caused by a magnetic stimulation device. The system comprises a stimulation circuit; a magnetic stimulation device configured to be driven by the stimulation circuit to create a pulsed magnetic field; a signal generator; a power source configured to provide power to the signal generator; and at least one conductor used with the magnetic stimulation device. The signal generator is configured to provide a signal to the at least one conductor to cause the at least one conductor to generate a second magnetic field.


Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Neuromodulation Devices Market by Technologies, Geography, Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc. Maryland Heights, MO, May 04, 2017 --( Browse Neuromodulation Devices Market by Technology (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/ The global neuromodulation devices market segmentation is based on technology (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices). The global neuromodulation devices market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global global neuromodulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global neuromodulation devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. Major players operating in the global neuromodulation devices market and included in this report are Boston Scientific Group, Cyberonics, Nevro, Medtronic, Neuronetics Inc., St. Jude Medical, and Uroplasty. 1. Technology 1.1 Spinal Cord Stimulation Devices 1.2 Deep Brain Stimulation Devices 1.3 Sacral Nerve Stimulation Devices 1.4 Vagus Nerve Stimulation Devices 1.5 Gastric Electric Stimulation Devices 2. Geography (Region, Country) 2.1 North America (U.S., Canada) 2.2 Latin America (Brazil, Mexico, Rest of LA) 2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 2.4 Asia Pacific (Japan, China, India, Rest of APAC) 2.5 Rest of the World 3. Company Profiles 3.1 Boston Scientific 3.2 Cyberonics 3.3 Medtronics 3.4 Nervo 3.5 Neurotics, Inc. 3.6 St. Jude Medical 3.7 Uroplasty To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, May 04, 2017 --( PR.com )-- Neuromodulation devices are medical devices used to curb chronic diseases and are used for effective pain management. The devices function by producing electrical impulses to create paraesthesia or numbness in the target area. Neuromodulation device technology is a relatively new concept and is proving to be extremely effective in managing chronic diseases. Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous system, the autonomic nervous system and the deep cell nuclei of the brain, resulting in modulation of their activity. It can be used to treat movement disorders, spasticity, epilepsy as well as pain syndromes.Browse Neuromodulation Devices Market by Technology (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/The global neuromodulation devices market segmentation is based on technology (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices).The global neuromodulation devices market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global global neuromodulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global neuromodulation devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.Major players operating in the global neuromodulation devices market and included in this report are Boston Scientific Group, Cyberonics, Nevro, Medtronic, Neuronetics Inc., St. Jude Medical, and Uroplasty.1. Technology1.1 Spinal Cord Stimulation Devices1.2 Deep Brain Stimulation Devices1.3 Sacral Nerve Stimulation Devices1.4 Vagus Nerve Stimulation Devices1.5 Gastric Electric Stimulation Devices2. Geography (Region, Country)2.1 North America (U.S., Canada)2.2 Latin America (Brazil, Mexico, Rest of LA)2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)2.4 Asia Pacific (Japan, China, India, Rest of APAC)2.5 Rest of the World3. Company Profiles3.1 Boston Scientific3.2 Cyberonics3.3 Medtronics3.4 Nervo3.5 Neurotics, Inc.3.6 St. Jude Medical3.7 UroplastyTo request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


Patent
Neuronetics | Date: 2013-11-11

A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.


Patent
Neuronetics | Date: 2015-12-29

The inventive technique includes a system, method and device for treating a patient. The device includes a magnetic device having a core created by a binder process having a relatively low temperature. The device further includes a conductor in electrical communication with the core.


A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subjects brain. In another example, the magnetic field may exhibit increased penetration depth into the subjects brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subjects head).


Patent
Neuronetics | Date: 2015-02-10

A model of a human subjects head may be generated to assist in a therapeutic and/or diagnostic procedure. A treatment and/or diagnostic system may generate a fitted head model using a predetermined head model and a plurality of points. The plurality of points may include facial feature information and may be determined using a sensor, which may include an IR sensor. One or more anatomical landmarks may be determined and registered in association with the fitted head model using the facial feature information, for example, without the use of additional image information, such as an MRI image. The fitted head model may include visual aids, for example, anatomical landmarks, reference points, marking of the human subjects MT location, and/or marking of the human subjects treatment location. The visual aids may assist a technician to perform the therapeutic and/or diagnostic procedure of the human subject. The fitted head model may be stored.


Patent
Neuronetics | Date: 2013-07-10

The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.


A proximity sensor for a transcranial magnetic stimulation (TMS) system detects the proximity of a TMS coil assembly to a position at which the coil is to receive pulses during TMS treatment and provides feedback to the operator so that the operator may adjust the TMS coil assembly to maintain optimal positioning during treatment. A flexible substrate containing a sensor or sensor array is disposed between the TMS coil assembly and the position such that the coupling of the TMS coil assembly to the position may be detected by the sensor(s). Sensor outputs are processed by signal processing circuitry to provide an indication of whether the TMS coil assembly is properly disposed with respect to the position during TMS treatment. A display provides an indication of how to adjust the TMS coil assembly to improve the positioning of the TMS coil assembly.


Patent
Neuronetics | Date: 2012-01-12

The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.


A proximity sensor for a transcranial magnetic stimulation (TMS) system detects the proximity of a TMS coil assembly to a position at which the coil is to receive pulses during TMS treatment and provides feedback to the operator so that the operator may adjust the TMS coil assembly to maintain optimal positioning during treatment. A flexible substrate containing a sensor or sensor array is disposed between the TMS coil assembly and the position such that the coupling of the TMS coil assembly to the position may be detected by the sensor(s). Sensor outputs are processed by signal processing circuitry to provide an indication of whether the TMS coil assembly is properly disposed with respect to the position during TMS treatment. A display provides an indication of how to adjust the TMS coil assembly to improve the positioning of the TMS coil assembly.

Loading Neuronetics collaborators
Loading Neuronetics collaborators